June 2026 in “International Journal of Innovative Science and Research Technology (IJISRT)” This review explores both traditional Ayurvedic uses and modern scientific findings on Japa Pushpa (Hibiscus rosa-sinensis), suggesting it may benefit cardiovascular health and metabolic balance as a herbal tea, but emphasizes the need for further clinical validation.
This review outlines current treatments for folliculitis decalvans and dissecting cellulitis of the scalp, noting conventional therapies' limitations and promising but limited results from targeted biologic agents.
In this study, researchers using visual analysis reported a rising trend in platelet-rich plasma research from 2020 to 2024, with significant contributions from the United States and China, highlighting key applications in orthopedics, tissue engineering, and potential future focuses in neurogenic pain and regenerative medicine.
April 2026 in “Frontiers in Medicine” This study observed that 675-nm diode laser therapy may serve as a safe and possibly effective adjuvant treatment for telogen effluvium, showing improvements in hair pull test results, pruritus, and trichodynia among patients. However, controlled studies are needed to confirm its efficacy.
March 2026 in “Skin Appendage Disorders” This study reviewed multiple research articles and found that patients with telogen effluvium, primarily women, had significantly lower levels of serum ferritin and vitamin D compared to healthy controls, suggesting a role for trace element imbalances in hair loss.
This systematic review and meta-analysis found that patients with telogen effluvium, primarily females, exhibited significantly lower serum levels of ferritin and vitamin D compared to healthy controls, suggesting trace element imbalances play a crucial role in this type of hair loss.
This study found that telogen effluvium is strongly linked to lower serum levels of ferritin and vitamin D, especially in predominantly female patients.
This review discusses the mechanisms, scientific support, and FDA clearance of photobiomodulation mask devices but reports no new research findings.
This review found that exposure to pollutants like PM, NOx, and PAHs is linked to various skin and hair disorders, indicating a need for cosmetics with natural adsorbents to reduce pollutant effects, achieving 30-55% removal efficiency.
March 2026 in “Frontiers in Cell and Developmental Biology” This review synthesizes evidence that photobiomodulation may provide robust symptomatic relief for knee osteoarthritis but indicates its potential for structural regeneration remains speculative and needs further long-term validation.
January 2026 in “Skin Health and Disease” This study conducted a survey among consultant dermatologists in Ireland to explore their use of JAK inhibitors for treating alopecia areata, acknowledging challenges posed by the lack of global guidelines and long-term safety data.
January 2026 in “Dermatologic Therapy” In this systematic review and meta‐analysis, botulinum toxin monotherapy was found to significantly increase hair density in patients with androgenetic alopecia, with optimal effects observed using a 100-unit dose every six months. These findings suggest potential efficacy but should be confirmed in larger, placebo-controlled trials.
December 2025 in “The American Journal of Medical Sciences and Pharmaceutical Research” This study suggests that integrating barber care with medical treatment improves scalp condition and psychological well-being in early stages of hair loss, by enhancing medication efficacy and reducing stress.
November 2025 in “Journal of Clinical Medicine” This study found that platelet-rich plasma may improve patient-reported outcomes for scar symptoms like pain and itching at six months, although no significant changes in scar appearance were observed at three months.
October 2025 in “Journal of Pharmacy And Bioallied Sciences” This study concluded that platelet-rich plasma significantly improves hair density and patient satisfaction for individuals undergoing follicular unit extraction for androgenetic alopecia compared to those receiving the surgery alone.
October 2025 in “International Journal of Molecular Sciences” This review highlights the lack of a comprehensive synthesis of stem cell therapy research by categorizing current studies according to medical specialty and stem cell type, while analyzing their advantages and limitations across various medical disciplines.
September 2025 in “International Journal of Molecular Sciences” This article provides a clinical update on alopecia areata, highlighting the disease's multifactorial causes, challenges it presents, and the current treatment options, with a focus on comparing international guidelines and discussing comorbidities.
September 2025 in “BMJ Case Reports” This case report suggests that herpes zoster ophthalmicus with secondary preseptal cellulitis may occur as a rare adverse reaction following platelet-rich plasma injections for androgenetic alopecia.
September 2025 in “Clinical Cosmetic and Investigational Dermatology” This analysis concluded that mesenchymal stem cell-derived exosome therapy may offer a promising and safe approach for hair restoration, especially in androgenetic alopecia, despite limitations in study consistency and size.
August 2025 in “The American Journal of Medical Sciences and Pharmaceutical Research” This study suggests that noninvasive carboxytherapy methods, like gel formulations and device-assisted delivery, can significantly improve skin conditions with high safety and no recovery time, particularly in sensitive areas.
August 2025 in “Journal of Cosmetic Dermatology” In this systematic review, researchers examined various treatments for axillary hyperpigmentation, finding that Q-switched Nd:YAG laser and intense pulsed light showed significant improvement with minimal adverse effects; desonide and Cyperus rotundus oil were also notably effective among topical treatments.
June 2025 in “Journal of Education Health and Sport” This review highlights that while finasteride and minoxidil effectively treat androgenetic alopecia, emerging options like dutasteride, mesotherapy, androgen blockers, and red LED therapy show promising results, especially when used in combination, though further research is needed for standardization and safety confirmation.
May 2025 in “Medicine and ecology” This literature review highlights the widespread use of platelet-rich plasma in medicine but notes inconclusive evidence for its clinical efficacy due to specimen variability and unresolved methodological issues.
May 2025 in “International Journal of Trichology” In this report, four cases of noncicatricial alopecia developed following a single session of dutasteride mesotherapy in patients with androgenetic alopecia, highlighting potential adverse effects and the need for careful monitoring of the drug's composition.
This review concludes that platelet-rich plasma is a promising treatment for androgenetic alopecia, enhancing hair density and thickness, though outcomes vary due to differences in preparation and application methods.
January 2025 in “Open Science Framework” This review critically assesses recent evidence (2020-2025) on the effectiveness of regenerative therapies like platelet-rich plasma, photobiomodulation, stem cells, and exosomes for treating androgenetic alopecia, highlighting the challenges physicians face due to commercialization and the evolving regulatory landscape.
December 2024 in “Cermin Dunia Kedokteran” This source highlights that intraocular foreign bodies are urgent ophthalmologic emergencies requiring prompt diagnosis and treatment to prevent blindness and eye loss, with most cases involving the posterior segment of the eye.
August 2024 in “PLoS ONE” This study reviewed randomized controlled trials to assess whether adding platelet-rich plasma injections to a Minoxidil regimen offers any benefit in treating androgenetic alopecia, but results are not reported in the abstract.
This review suggests that injectable platelet-rich fibrin therapy shows promise for improving hair density in androgenetic alopecia and enhancing facial skin texture and elasticity, but larger studies are needed to confirm its effectiveness.
January 2019 in “Dermatologic Surgery” This abstract introduces the Dermatologic Surgery journal as a leading source of comprehensive and up-to-date information on cosmetic and reconstructive skin surgery and skin cancer. It highlights the journal's wide range of peer-reviewed content, making it essential reading for professionals in dermatology and related fields.